Market Definition:
At an estimated value of over USD 275.3 million in 2019, the Global Metagenomics Market is predicted to thrive at a CAGR of 14.5% and valued at over USD 1.22 billion over the forecast year 2020-2030. Metagenomics encompasses various studies that use bioinformatic tools as well as sequencing technologies to attain valuable understanding on the varieties in the microbial community and microbes’ interaction in a community. These studies are making advancements across environmental & clinical microbiology, despite considerable barriers such as difficulty to enable a microbial culture, which is a method of multiplying microbial organisms. The technologies in metagenomics have allowed enhanced understanding of the microbial ecosystem along with the role of microbiology in the geochemical cycles. This has led to the understanding of the enormous microbial diversity for researchers, fueling the global market growth.
Market Dynamics and Trends:
The global metagenomics market is majorly driven by factors such as rise in investments across the development of bioinformatics platforms to support microbiome profiling & metagenomics and increasing applications of metagenomics across various fields such as identification of novel biocatalysts, personalized medicine, discovery of new antibiotics, and bioremediation. Also, funding as well as initiatives from private bodies and government for large-scale sequencing projects is anticipated to promote the growth of metagenomics market. However, lack of awareness about metagenomics is expected to hamper the market growth during the forecast period. Contradictorily, the adoption of cloud computing for data management in the field of metagenomics is expected to create opportunities, which will further propel the metagenomics market growth.
Market Segmentations and Scope of the Study:
The global metagenomics market share is segmented on the basis of product, technology, application, and geography. On the basis of product type, the market is categorized into instrument & software and consumable. On the basis of technology, the market is segmented into bioinformatics and sequencing. On the basis of application, the market is segmented into infectious disease diagnosis, environmental remediation, biotechnology, gut microbe characterization, biofuel, and agriculture. Geographic fragmentation and analysis of each segment includes regions comprising North America, Europe, Asia Pacific and RoW.
Geographical Analysis:
In terms of geography, North America held major share of the market in 2019. This is due to the growing adoption of DNA sequencing across metagenomic applications in the region. In addition, surge in the implementation of novel sequencing technologies across the region has significantly contributed to its dominance. However, Asia pacific is expected to grow rapidly with increasing market size due to the significant patient pool as well as the rapidly evolving healthcare infrastructure in countries such as China, India, and Japan.
Competitive Landscape:
Maximum growth opportunities make the metagenomics market highly competitive. Some of the major players in the market are Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Enterome SA, Illumina, Inc., Pacific Biosciences of California, Inc., Oxford Nanopore Technologies Ltd., PerkinElmer, Inc., Swift Biosciences, Inc., Qiagen N.V., Thermo Fisher Scientific, Inc., and many more. A number of developmental strategies have been adopted by companies in the past few years. For instance, in February 2019, Agilent Technologies, Inc. launched a new next-generation sequencing (NGS) library preparation system which is designed for easily running the complex DNA sequencing assays. This fully automated Magnis NGS Prep System encompasses reagents and protocols that enables an easy examination of multiple genes & complex genetic aberrations from genomic DNA, such as degraded samples including formalin-fixed paraffin embedded (FFPE).
KEY MARKET SEGMENTS:
Global Metagenomics Market- By Product
Global Metagenomics Market - By Technology
Global Metagenomics Market - By Application
Global Metagenomics Market - By Geography
At an estimated value of over USD 275.3 million in 2019, the Global Metagenomics Market is predicted to thrive at a CAGR of 14.5% and valued at over USD 1.22 billion over the forecast year 2020-2030. Metagenomics encompasses various studies that use bioinformatic tools as well as sequencing technologies to attain valuable understanding on the varieties in the microbial community and microbes’ interaction in a community. These studies are making advancements across environmental & clinical microbiology, despite considerable barriers such as difficulty to enable a microbial culture, which is a method of multiplying microbial organisms. The technologies in metagenomics have allowed enhanced understanding of the microbial ecosystem along with the role of microbiology in the geochemical cycles. This has led to the understanding of the enormous microbial diversity for researchers, fueling the global market growth.
Market Dynamics and Trends:
The global metagenomics market is majorly driven by factors such as rise in investments across the development of bioinformatics platforms to support microbiome profiling & metagenomics and increasing applications of metagenomics across various fields such as identification of novel biocatalysts, personalized medicine, discovery of new antibiotics, and bioremediation. Also, funding as well as initiatives from private bodies and government for large-scale sequencing projects is anticipated to promote the growth of metagenomics market. However, lack of awareness about metagenomics is expected to hamper the market growth during the forecast period. Contradictorily, the adoption of cloud computing for data management in the field of metagenomics is expected to create opportunities, which will further propel the metagenomics market growth.
Market Segmentations and Scope of the Study:
The global metagenomics market share is segmented on the basis of product, technology, application, and geography. On the basis of product type, the market is categorized into instrument & software and consumable. On the basis of technology, the market is segmented into bioinformatics and sequencing. On the basis of application, the market is segmented into infectious disease diagnosis, environmental remediation, biotechnology, gut microbe characterization, biofuel, and agriculture. Geographic fragmentation and analysis of each segment includes regions comprising North America, Europe, Asia Pacific and RoW.
Geographical Analysis:
In terms of geography, North America held major share of the market in 2019. This is due to the growing adoption of DNA sequencing across metagenomic applications in the region. In addition, surge in the implementation of novel sequencing technologies across the region has significantly contributed to its dominance. However, Asia pacific is expected to grow rapidly with increasing market size due to the significant patient pool as well as the rapidly evolving healthcare infrastructure in countries such as China, India, and Japan.
Competitive Landscape:
Maximum growth opportunities make the metagenomics market highly competitive. Some of the major players in the market are Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Enterome SA, Illumina, Inc., Pacific Biosciences of California, Inc., Oxford Nanopore Technologies Ltd., PerkinElmer, Inc., Swift Biosciences, Inc., Qiagen N.V., Thermo Fisher Scientific, Inc., and many more. A number of developmental strategies have been adopted by companies in the past few years. For instance, in February 2019, Agilent Technologies, Inc. launched a new next-generation sequencing (NGS) library preparation system which is designed for easily running the complex DNA sequencing assays. This fully automated Magnis NGS Prep System encompasses reagents and protocols that enables an easy examination of multiple genes & complex genetic aberrations from genomic DNA, such as degraded samples including formalin-fixed paraffin embedded (FFPE).
KEY MARKET SEGMENTS:
Global Metagenomics Market- By Product
- Instrument & Software
- Consumable
Global Metagenomics Market - By Technology
- Sequencing
- Bioinformatics
Global Metagenomics Market - By Application
- Infectious Disease Diagnosis
- Environmental Remediation
- Biotechnology
- Gut Microbe Characterization
- Biofuel
- Agriculture
Global Metagenomics Market - By Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Taiwan
- Rest of Asia-Pacific
- Rest of World
- Brazil
- Turkey
- Saudi Arabia
- South Africa
- Remaining Countries
Table of Contents
1. Introduction
2. Market Snapshot, 2019-2030 Million USD
4. Market Dynamics
5. Global Metagenomics Market, by Technology
6. Global Metagenomics Market, by Product
7. Global Metagenomics Market, by Application
8. Global Metagenomics Market, by Region
9. Company Profiles
Executive Summary
Metagenomics: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2020 - 2030. Funding as well as initiatives from private bodies and government for large-scale sequencing projects are factors driving the metagenomics market growth.Metagenomics encompasses various studies that use bioinformatic tools as well as sequencing technologies to attain valuable understanding on the varieties in the microbial community and microbes’ interaction in a community. The global metagenomics market is majorly driven by factors such as rise in investments across the development of bioinformatics platforms to support microbiome profiling & metagenomics and increasing applications of metagenomics across various fields such as identification of novel biocatalysts, personalized medicine, discovery of new antibiotics, and bioremediation. However, lack of awareness about metagenomics is expected to hamper the market growth during the forecast period.
The global metagenomics market share is segmented on the basis of product, technology, application, and geography. On the basis of product type, the market is categorized into instrument & software and consumable. On the basis of technology, the market is segmented into bioinformatics and sequencing. On the basis of application, the market is segmented into infectious disease diagnosis, environmental remediation, biotechnology, gut microbe characterization, biofuel, and agriculture. Geographic fragmentation and analysis of each segment includes regions comprising North America, Europe, Asia Pacific and RoW.
Companies Mentioned
A selection of companies mentioned in this report includes:
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche Ltd.
- Enterome SA
- Illumina, Inc.
- Pacific Biosciences of California, Inc.
- Oxford Nanopore Technologies Ltd.
- PerkinElmer, Inc.
- Swift Biosciences, Inc.
- Qiagen N.V.
- Thermo Fisher Scientific, Inc.
